Douglas P Clark

Title: Douglas P. Clark: Innovator in Drug Sensitivity and Cellular Analysis

Introduction

Douglas P. Clark is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the fields of drug sensitivity and cellular analysis, holding 2 patents that reflect his innovative work. His research focuses on improving diagnostic methods and therapeutic outcomes for patients, particularly in the realm of cancer treatment.

Latest Patents

One of Douglas P. Clark's latest patents is titled "Compositions and methods for prediction of drug sensitivity, resistance, and disease progression." This invention is based on the discovery that functional stratification and signaling profiles can be utilized for diagnosing disease status and determining drug resistance or sensitivity in cancer cells. The patent outlines assays for diagnosis and prognosis of diseases, as well as methods for evaluating the resistance or sensitivity of diseases to targeted therapeutic agents. Another significant patent is "Methods and devices for cellular analysis," which presents improved techniques and devices for analyzing cells, aggregated cells, or solid tumors. These advancements are particularly useful in pathology, enhancing cell processing and analytical results.

Career Highlights

Douglas P. Clark is currently associated with Biomarker Strategies, LLC, where he continues to develop innovative solutions in the medical field. His work has the potential to transform how diseases are diagnosed and treated, particularly in oncology.

Collaborations

He collaborates with notable colleagues such as Adam Schayowitz and Kathleen M. Murphy, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Douglas P. Clark's contributions to drug sensitivity and cellular analysis exemplify the impact of innovation in healthcare. His patents not only advance scientific understanding but also hold promise for improving patient outcomes in the future.